Boron-containing compounds (BCC) have emerged as important pharmacophores. To date,
five BCC drugs (including boronic acids and boroles) have been approved by the FDA for …

The continued emergence of nanoscale materials for nanoparticle-based therapy, sensing
and imaging, as well as their more general adoption in a broad range of industrial …

Carboranes are promising agents for applications in boron neutron capture therapy (BNCT),
but their hydrophobicity prevents their use in physiological environments. Here, by using …

The luminal A-subtype of breast cancer, where the oestrogen receptor α (ERα) is
overexpressed, is the most frequent one. The prodrug tamoxifen (1) is the clinically used …

Healthcare systems heavily rely on antibiotics to treat bacterial infections, but the
widespread presence of multidrug-resistant bacteria puts this strategy in danger. Novel …

Multiplex optical detection in live cells is challenging due to overlapping signals and poor
signal‐to‐noise associated with some chemical reporters. To address this, the application of …

Intracellular delivery of nano‐drug‐carriers (NDC) to specific cells, diseased regions, or
solid tumors has entered the era of precision medicine that requires systematic knowledge …

Ruthenium-based complexes have received much interest as potential metallodrugs. In this
work, four RuII complexes bearing a dicarbollide moiety, a carbonyl ligand, and a …

A total activity of∼ 10 19 Bq, including∼ 10 16 Bq of 137 Cs, was released from the
Fukushima Daiichi Nuclear Power Plant (FDNPP) in 2011, among which 137 Cs (30.1 years …

One of the most pressing issues nowadays is to control and reduce environmental pollution
produced by human activities through industrialization and urbanization. Apart from gaseous …